Drug Pipeline

Tezepelumab Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
34
Active Studies
17
Recruiting
14
Phase 3
10
Top Sponsors
6
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-02 NCT04552288
Study of Benralizumab in People With Skin Side Effects Caused by Cancer Therapies
Trial completed
2026-06-02 NCT04552288
Study of Benralizumab in People With Skin Side Effects Caused by Cancer Therapies
date change Completion moved earlier: 2027-03-16 -> 2026-05-12
2026-05-30 NCT06512883
A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases
date change Completion pushed: 2028-04-03 -> 2029-05-14
2026-05-27 NCT07520162
A Study to Investigate NPS and Symptoms in Chinese Adult Participants With CRSwNP…
Recruitment opened
2026-05-27 NCT07520162
A Study to Investigate NPS and Symptoms in Chinese Adult Participants With CRSwNP…
Trial sites reduced: 51 -> 1 locations
2026-05-27 NCT07520162
A Study to Investigate NPS and Symptoms in Chinese Adult Participants With CRSwNP…
date change Completion moved earlier: 2028-08-15 -> 2028-03-07
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-05-18 NCT07591753 Long-Term Safety and Effectiveness of Mepolizumab 300 mg in Europe (Mepo LTF Study) Completed
2026-05-18 NCT07592104 Effectiveness on Sino-Nasal Symptoms Of Mepolizumab 300 Completed
Active Studies by Phase
Phase 4
3
Phase 3
14
Phase 2
7
Phase 1
2
Early Phase 1
1
Not specified
7
Active Trials — top 25 of 34
NCT IDTitleConditionStatus
Phase 4
NCT07343661 Beyond EOsinophils: proteoMICS to Identify Potential Biomarker of Organ Damage and… EGPA - Eosinophilic Granulomatosis With Polyangiitis Enrolling by Invitation
NCT06705764 Tezepelumab in the Treatment of Emergency Room Asthma in Adults (TERAA) Severe Asthma Not Yet Recruiting
NCT03953300 Benralizumab Airway Remodeling Study in Severe Eosinophilic Asthmatics Asthma Active, Not Recruiting
Phase 3
NCT06878261 A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With… Chronic Obstructive Pulmonary Disease (COPD) Recruiting
NCT06883305 A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With… Chronic Obstructive Pulmonary Disease (COPD) Recruiting
NCT07363642 Phase 3b Study in Patients With Severe Asthma Treated With Tezepelumab Severe Asthma Recruiting
NCT07520162 A Study to Investigate NPS and Symptoms in Chinese Adult Participants With CRSwNP… Chronic Rhinosinusitis With Nasal Polyps Recruiting
NCT06512883 A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases Eosinophilic Granulomatosis With Polyangiitis (EGPA) Recruiting
NCT05692180 A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled… Asthma Recruiting
NCT06023589 A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in… Asthma Recruiting
NCT04191304 A Phase III Study to Evaluate the Efficacy and Safety of Benralizumab in Patients With… Hypereosinophilic Syndrome Active, Not Recruiting
NCT07444567 Roll-over Study for Participants Who Have Completed a Previous Clinical Study With… Asthma Not Yet Recruiting
NCT05583227 Efficacy and Safety of Tezepelumab in Patients With Eosinophilic Esophagitis Eosinophilic Esophagitis Active, Not Recruiting
NCT06365879 To Compare Efficacy and Safety of CMAB007 and Xolair® in Patients With Chronic… Chronic Spontaneous Urticaria Active, Not Recruiting
NCT04157348 Efficacy and Safety of Benralizumab in EGPA Compared to Mepolizumab. Eosinophilic Granulomatous Vasculitis Active, Not Recruiting
NCT06465485 STEP: Phase IIIb Study of Benralizumab to Step-down Maintenance Therapy in Patients With… Severe Eosinophilic Asthma Active, Not Recruiting
NCT06042478 Phase 3b Study to Assess the Efficacy, Safety, and Tolerability of Remibrutinib in… Chronic Spontaneous Urticaria Active, Not Recruiting
Phase 2
NCT07342803 Efficacy, Safety, and Pharmacokinetics of LP-003 Injection in Allergic Asthma Patients Allergic Asthma Recruiting
NCT07059091 Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD Chronic Obstructive Pulmonary Disease (COPD) Recruiting
NCT06934200 Omalizumab for the Treatment of Food Allergy in Patients With Elevated Total IgE Levels Food Hypersensitivity Recruiting
NCT06189742 Tezepelumab in Allergic Rhinitis and Asthma Study (TEZARS) Asthma With Allergic Rhinitis Active, Not Recruiting
NCT06230354 Explore the Efficacy and Mechanism of Action of Tezepelumab in Eosinophilic… EGPA - Eosinophilic Granulomatosis With Polyangiitis Active, Not Recruiting
NCT06734884 Interest of a Targeted Therapy for the Treatment of a Severe Form of Hypersensitivity to… DRESS Syndrome Not Yet Recruiting
NCT07015996 Efficacy of Tezepelumab in Peanut Oral Immunotherapy Peanut Allergy Not Yet Recruiting
Phase 1
NCT07356713 A Study to Find a Suitable Dose of Exl-111 for Further Research Allergic Disease Recruiting
Sponsors Running Tezepelumab Trials
Disease Areas
Get alerts when Tezepelumab trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free